In Chronic Fatigue and its Syndromesl Wessely, Hotopf and Sharpe review historical, psychological, clinical and scientific research about fatigue as a feeling, as a symptom, and as a cardinal component of fatigue syndromes. In the current period of renewed interest in fatigue mechanisms2, they offer a comprehensive overview of a rapidly developing and diverse field of knowledge. As the authors indicate, many cognate meanings are encompassed by the term fatigue the sensation of exhaustion that follows exertion; the subjective feeling of increased effort required to accomplish a task (when fatigue accompanies actions); or the psychological and spiritual lethargy felt at the prospect of engaging in physical or mental work. Originating from 17th century French, the term initially signalled profound weariness. By the 19th century it could also refer to 'a condition of weakness in metals caused by repeated blows or strains'3. Equating fatigue (even by metaphor) with a state induced by stresses acting upon metals, imputes a species of human incapacity that can arise sociogenically-as a by-product of the effect of society (or civilization) upon vulnerable individuals. Such a notion prepares us conceptually for some of the themes that Wessely and his coauthors have woven throughout the book. Considerations of epistemology (how can we know and recognize such medical conditions?), of nosology (how should syndromes of chronic fatigue be classified?), and of disease ontology (do such syndromes really exist independently of other diseases?) are its leitmotifs.
The book begins with a review of the clinical phenomenology of fatigue. Like pain, it is a complex and almost universal human experience, at least from the teenage years, but fatigue inhabits a territory less explored by medicine. Many potential contours can be discerned upon the amorphous experiences we describe as lethargy, exhaustion or ennui feelings of interest, boredom, attraction and aversion; of mood, anxiety and depression; of disturbances in sleep, libido and behavioural performance. Such component markings may exert effects upon how we choose to interpret fatigue. Answers to questions such as: 'Am I ill, just tired, or profoundly over-tired?' are likely to be as strongly influenced by these associated features of fatigue experience as by the dimensional aspects of its perceived duration and severity.
Factors clinically associated with fatigue frequently raise the diagnostic possibility of it being the result of underlying physical disorders; odds ratios for tiredness in the general population show self-perceived physical illnesses to be significant risk factors (as are being female, taking a lot of exercise, and belonging to social class 4 or 5)1. But even where disease is clearly causally related to fatigue, Wessely et al. find secondary psychological factors such as mood, illness beliefs, emotional distress, and effects occasioned by medical treatments (including rest cures) to be more important determinants of whether or not fatigue is felt than is the presence or absence of chronic disease. In a review of published research they find no evidence of common physiological mechanisms that convincingly account for many of the features of tiredness. As yet, there is no reliable laboratory test of fatigue, and measures of disease activity correlate poorly with intensities of fatigue felt; perceptions of tiredness in chronic heart failure, for example, relate better to the demands of test workloads across different severities of cardiac failure than they do to objective measures of cardiac disease severity1.
The notion of a syndrome characterized by profound lethargy, made worse by minimal physical or mental exertion, in patients for whom clear-cut physical or psychiatric diagnoses cannot be established, lies at the core of the modem concept of chronic fatigue syndrome (CFS). The authors believe recognition of a syndrome characterized by 'easy fatigability'4 can be traced back to the 19th century disease complex 'neurasthenia', a state of enfeeblement 'without organic lesion' that became a maladie a' la mode by the end of the 19th century.
In the 50 years following its mid-century description, neurasthenia's protean manifestations became renowned5, and theories concerning its aetiology and pathogenesis oscillated from the entirely physical to the purely psychological; between the assumption that it was a real (though inconclusively demonstrated) disease to the belief that it was a disabling disease imaginaire. By the early 20th century, 'Nervous exhaustion, characterised by undue fatigue on slightest exertion, both physical and mental . .. the chief symptoms are headache, gastrointestinal disturbances, and subjective sensations of all kinds6' was how it was characterized by one observer of the syndrome.
Wessely et al. point to the possible mutation of neurasthenia into what we now recognize as myalgic encephalomyelitis (ME). Given the lack of a clear epidemic 4 0 0 47 or contagious aspect to neurasthenia (though fever, sometimes linked to infectious triggers had been part of the complex), and the incontrovertible epidemic nature of the initial phenomena denoted by ME in the 1 950s, it requires almost an act of faith to believe that substitution of the new term for the old allows reference to a similar disease complex. In the end, the authors side with Jenkins' appraisal7 of the outbreaks of weakness, myalgia, sensory symptoms and emotional disturbance which took place at the Los Angeles County Hospital in 1934 and at the Royal Free Hospital in 1955-that 'the majority of cases were a hysterical reaction to a small number of poliomyelitis cases among the staff.'
How transfer of the label ME, designating an epidemic condition, to one designating a sporadic condition actually took place remains obscure, though mislabelling may have played a part. Contemporaneous neurobiological and viral studies failed to supply convincing evidence of a neurological or viral basis to either ailment. Many different scientific, conceptual and cultural influences have played a part in attempts to define CFS during the last quarter of the 20th century. Defined operationally now, it is a syndrome which, after much campaigning, bears the stamp of medical, social and political legitimacy8.
It has been said that, in our culture, 'a disease does not exist as a social phenomenon until we agree that it does'9.
The attempt to chart historical continuities in the 'sickness stylistics'10 of CFS makes for absorbing reading. But the reader is left with a sense that historical continuities are emphasized at the expense of discontinuities, and that a lot more research in this area remains to be undertaken.
In the final third of the book, the authors turn their attention to clinical assessment and treatment of CFS. Within a biopsychosocial approach to patient management, evidence for the effectiveness of different treatments is appraised. They attach most value to programmes of cognitive behaviour therapy that focus upon education, advice, and graded exercisell. With many snippets of CFS narrative and doctor-patient dialogue, the reader can 'watch' experienced clinicians negotiating treatment biopsychosocially with their patients. An example will give the flavour: in the authors' view, antidepressants are worth offering to sufferers who report depressed mood. Without omitting discussion of major side-effects, they explain the potential benefits in holistic terms: 'We commonly (and truthfully) justify their use by describing them as "broad spectrum" agents that can improve pain, sleep, and energy, as well as mood', and thereby diminish the stigmatized psychiatric connotations of such medication.
Wessely and his colleagues have performed a valuable service in creating this source book for some of the most intriguing symptoms and syndromes of modern times. Their labours will prove rewarding to clinicians and researchers alike wishing to invigorate their practices with an overview drawn from diverse intellectual perspectives, and enriched by much clinical experience.
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